MCM
WVE icon

Moore Capital Management’s Wave Life Sciences WVE Stock Holding History

Moore Capital Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-15,000
Closed -$127K – 610
2020
Q3 		$127K Buy
+15,000
New +$164K ﹤0.01% 355
2019
Q2 		– Sell
-36,600
Closed -$1.42M – 392
2019
Q1 		$1.42M Buy
+36,600
New +$1.49M 0.04% 219

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Moore Capital Management's WVE Position: Q4 2020 in Review

Moore Capital Management sold out of Wave Life Sciences (WVE) in Q4 2020, closing a stake of 15,000 shares — an estimated $127K sold.

Moore Capital Management first reported a position in WVE in Q1 2019 and held it in 2 quarters. The position peaked at $1.42M in Q1 2019. 108 funds tracked by Wall St. Rank hold WVE as of Q4 2020.

  • Moore Capital Management reported no remaining Wave Life Sciences position as of Q4 2020 after selling out during the quarter.
  • Moore Capital Management sold 15,000 Wave Life Sciences shares in Q4 2020, an estimated $127K.
  • Moore Capital Management first reported a position in Wave Life Sciences in Q1 2019 and held it in 2 quarters.
  • Moore Capital Management's Wave Life Sciences position peaked at $1.42M in Q1 2019.
  • 108 funds tracked by Wall St. Rank held Wave Life Sciences as of Q4 2020.

Based on Moore Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.